Human lithostathine S2-5: a relevant inhibitor of pancreatic stone formation?
Bimmler
D
D
Department of Surgery, University Hospital, Zürich, Switzerland.
Graf
R
R
Frick
T
T
D002119:Calcium Carbonate / Q000737:chemistry; D002135:Calcium-Binding Proteins / Q000032:analysis / Q000494:pharmacology*; D002908:Chronic Disease; D003460:Crystallization; D006801:Humans; D020347:Lithiasis / Q000517:prevention & control*; D051847:Lithostathine; D009419:Nerve Tissue Proteins; D010182:Pancreatic Diseases / Q000517:prevention & control*; D010183:Pancreatic Ducts; D010189:Pancreatic Juice / Q000737:chemistry; D010195:Pancreatitis / Q000378:metabolism
D002135:Calcium-Binding Proteins; D051847:Lithostathine; D009419:Nerve Tissue Proteins; C497617:REG1A protein, human; D002119:Calcium Carbonate